Clinical Trial Update: Ixazomib + Pomalidomide + Dexamethasone In MM [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating ixazomib, pomalidomide, and dexamethasone in multiple myeloma, including relapsed disease. The study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• NINLARO (ixazomib)
• Pomalyst (pomalidomide)

Snippet

Sponsor: Omar Nadeem, MD | Conditions: Multiple Myeloma, Multiple Myeloma in Relapse | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING